Matches in SemOpenAlex for { <https://semopenalex.org/work/W4244376018> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4244376018 endingPage "36" @default.
- W4244376018 startingPage "31" @default.
- W4244376018 abstract "Background and Objectives The present study compared the effects of sequential methotrexate and fluorouracil followed by leucovorin rescue (MFL), as an adjuvant chemotherapy vs. UFT (a combination of uracil and tegafur), on patient survival and recurrence following surgery for advanced gastric carcinoma. Methods Between July 1990 and June 1998, a total of 54 patients with advanced gastric cancer were treated postoperatively by adjuvant chemotherapy using MFL or UFT. Surgical treatment was performed according to standardized procedures for radical resection of gastric cancer. The patients were stratified into two groups following surgery. The MFL regimen consisted of methotrexate (100 mg/m2) and 5-fluorouracil (600 mg/m2) at hour 3, followed by leucovorin rescue. The oral UFT (375 mg/m2/day), a combination of tegafur and uracil in a molar ratio of 1:4, was continued for 3 years or longer depending on the patients tolerance. Results In stage 3 gastric cancer, the overall survival rates following surgery was significantly (p < 0.05) higher in the MFL than the UFT group. Difference in disease free survival was not statistically significant between the groups. Recurrence rates showed a trend (p = 0.08) to decrease in the MFL than the UFT group. In stage 4 gastric cancer, no significant difference was obtained in the overall survival rates between the groups. Conclusions The present results suggested the superiority of MFL treatment for improving postoperative survival in patients with advanced gastric cancer, in particular for those patients with a high risk of recurrence following potential curative resection. In patients with stage 4 gastric cancer, however, MFL treatment showed similar effects as UFT on the postsurgical survival of the patients. J. Surg. Oncol. 2000:75:31–36. © 2000 Wiley-Liss, Inc." @default.
- W4244376018 created "2022-05-12" @default.
- W4244376018 creator A5005114022 @default.
- W4244376018 creator A5014831833 @default.
- W4244376018 creator A5035687666 @default.
- W4244376018 creator A5048728614 @default.
- W4244376018 creator A5059916259 @default.
- W4244376018 date "2000-09-01" @default.
- W4244376018 modified "2023-09-26" @default.
- W4244376018 title "Postsurgical sequential methotrexate, fluorouracil, and leucovorin for stages 3 and 4 gastric carcinoma: A preliminary study" @default.
- W4244376018 doi "https://doi.org/10.1002/1096-9098(200009)75:1<31::aid-jso6>3.3.co;2-h" @default.
- W4244376018 hasPublicationYear "2000" @default.
- W4244376018 type Work @default.
- W4244376018 citedByCount "0" @default.
- W4244376018 crossrefType "journal-article" @default.
- W4244376018 hasAuthorship W4244376018A5005114022 @default.
- W4244376018 hasAuthorship W4244376018A5014831833 @default.
- W4244376018 hasAuthorship W4244376018A5035687666 @default.
- W4244376018 hasAuthorship W4244376018A5048728614 @default.
- W4244376018 hasAuthorship W4244376018A5059916259 @default.
- W4244376018 hasConcept C121608353 @default.
- W4244376018 hasConcept C126322002 @default.
- W4244376018 hasConcept C141071460 @default.
- W4244376018 hasConcept C146357865 @default.
- W4244376018 hasConcept C151730666 @default.
- W4244376018 hasConcept C2776283816 @default.
- W4244376018 hasConcept C2776694085 @default.
- W4244376018 hasConcept C2777299880 @default.
- W4244376018 hasConcept C2780456651 @default.
- W4244376018 hasConcept C2781059491 @default.
- W4244376018 hasConcept C2781413609 @default.
- W4244376018 hasConcept C71924100 @default.
- W4244376018 hasConcept C86803240 @default.
- W4244376018 hasConcept C90924648 @default.
- W4244376018 hasConceptScore W4244376018C121608353 @default.
- W4244376018 hasConceptScore W4244376018C126322002 @default.
- W4244376018 hasConceptScore W4244376018C141071460 @default.
- W4244376018 hasConceptScore W4244376018C146357865 @default.
- W4244376018 hasConceptScore W4244376018C151730666 @default.
- W4244376018 hasConceptScore W4244376018C2776283816 @default.
- W4244376018 hasConceptScore W4244376018C2776694085 @default.
- W4244376018 hasConceptScore W4244376018C2777299880 @default.
- W4244376018 hasConceptScore W4244376018C2780456651 @default.
- W4244376018 hasConceptScore W4244376018C2781059491 @default.
- W4244376018 hasConceptScore W4244376018C2781413609 @default.
- W4244376018 hasConceptScore W4244376018C71924100 @default.
- W4244376018 hasConceptScore W4244376018C86803240 @default.
- W4244376018 hasConceptScore W4244376018C90924648 @default.
- W4244376018 hasIssue "1" @default.
- W4244376018 hasLocation W42443760181 @default.
- W4244376018 hasOpenAccess W4244376018 @default.
- W4244376018 hasPrimaryLocation W42443760181 @default.
- W4244376018 hasRelatedWork W1970701813 @default.
- W4244376018 hasRelatedWork W1979187129 @default.
- W4244376018 hasRelatedWork W2035637340 @default.
- W4244376018 hasRelatedWork W2052846931 @default.
- W4244376018 hasRelatedWork W2059846043 @default.
- W4244376018 hasRelatedWork W2334004086 @default.
- W4244376018 hasRelatedWork W2390046741 @default.
- W4244376018 hasRelatedWork W2411749020 @default.
- W4244376018 hasRelatedWork W2627069090 @default.
- W4244376018 hasRelatedWork W3086613149 @default.
- W4244376018 hasVolume "75" @default.
- W4244376018 isParatext "false" @default.
- W4244376018 isRetracted "false" @default.
- W4244376018 workType "article" @default.